All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Citations Report

Citation Index - Clinical Practice [2593 Articles]

The articles published in Clinical Practice have been cited 2593 times by eminent researchers all around the world. Following is the list of articles that have cited the articles published in Clinical Practice.

  • Duan J, Chen J, Yin Q, Karan R, Meiser K, et al. 2012. Pharmacokinetics of single and multiple oral doses of valsartan/amlodipine (80/5 mg) in healthy Chinese subjects. International journal of clinical pharmacology and therapeutics, 50(1), pp.33-43.

    View at Publisher | View at Google Scholar
  • Effects of levamlodipine besylate and valsartan on hypertension in the treatment of hypertension. Chinese Journal of Integrative Medicine on Cardio / Cerebrovascular Diseases, 11 (5), pp.542-543.

    View at Publisher | View at Google Scholar
  • Fogari R and Zoppi A, 2010. Clinical benefits from combination therapy in the treatment of hypertension. Hipertensión y riesgo vascular, 27(3), pp.108-116.

    View at Publisher | View at Google Scholar
  • Hu Hailong, 2010. Clinical observation of enalapril combined with levamlodipine besylate in the treatment of essential hypertension. Chinese and foreign medical treatment, 29 (17), pp.101-102.

    View at Publisher | View at Google Scholar
  • Gorostidi M and De la Sierra A, 2010. Antagonistas de los receptores de la angiotensina II en combinación con antagonistas del calcio. Focus en la asociación de olmesartán con amlodipino. Hipertensión y Riesgo Vascular, 27, pp.16-21.

    View at Publisher | View at Google Scholar
  • Gorostidi M and De la Sierra A, 2010. Antagonistas de los receptores de la angiotensina II en combinación con antagonistas del calcio. Focus en la asociación de olmesartán con amlodipino. Hipertensión y Riesgo Vascular, 27, pp.16-21.

    View at Publisher | View at Google Scholar
  • Tautu O, Antohi I, Pantelimonescu V, Macovei V, Popescu EC, et al. 2016. Blood Pressure Control and Quality of Life in Hypertensive Patients Treated with Amlodipine/Valsartan Fixed Dose Combination–IMPROVE Study Results. Modern Medicine, 23(2), p.136.

    View at Publisher | View at Google Scholar
  • Clinical observation of valsartan combined with amlodipine in the treatment of essential hypertension. Chinese Journal of Medicine, 11 (36), pp. 7-8.

    View at Publisher | View at Google Scholar
  • Dégardin K, Roggo Y and Margot P, 2014. Understanding and fighting the medicine counterfeit market. Journal of pharmaceutical and biomedical analysis, 87, pp.167-175.

    View at Publisher | View at Google Scholar
  • Tabernero P, Fernández FM, Green M, Guerin PJ and Newton PN, 2014. Mind the gaps-the epidemiology of poor-quality anti-malarials in the malarious world-analysis of the WorldWide Antimalarial Resistance Network database. Malaria journal, 13(1), p.139.

    View at Publisher | View at Google Scholar
  • Galhena AS, Harris GA, Kwasnik M and Fernández FM, 2010. Enhanced direct ambient analysis by differential mobility-filtered desorption electrospray ionization-mass spectrometry. Analytical chemistry, 82(22), pp.9159-9163.

    View at Publisher | View at Google Scholar
  • Terent'ev AO, Borisov DA, Vil VA and Dembitsky VM, 2014. Synthesis of five-and six-membered cyclic organic peroxides: Key transformations into peroxide ring-retaining products. Beilstein journal of organic chemistry, 10(1), pp.34-114.

    View at Publisher | View at Google Scholar
  • Kaale E, Risha P and Layloff T, 2011. TLC for pharmaceutical analysis in resource limited countries. Journal of Chromatography A, 1218(19), pp.2732-2736.

    View at Publisher | View at Google Scholar
  • Green MD, Hostetler DM, Nettey H, Swamidoss I, Ranieri N, et al. 2015. Integration of novel low-cost colorimetric, laser photometric, and visual fluorescent techniques for rapid identification of falsified medicines in resource-poor areas: application to artemether–lumefantrine. The American journal of tropical medicine and hygiene, 92(6 Suppl), pp.8-16.

    View at Publisher | View at Google Scholar
  • Suleman S, Vandercruyssen K, Wynendaele E, D’Hondt M, Bracke N, et al. 2013. A rapid stability-indicating, fused-core HPLC method for simultaneous determination of β-artemether and lumefantrine in anti-malarial fixed dose combination products. Malaria journal, 12(1), p.145.

    View at Publisher | View at Google Scholar
  • Fadeyi I, Lalani M, Mailk N, Van Wyk A and Kaur H, 2015. Quality of the antibiotics—amoxicillin and co-trimoxazole from Ghana, Nigeria, and the United Kingdom. The American journal of tropical medicine and hygiene, 92(6 Suppl), pp.87-94.

    View at Publisher | View at Google Scholar
  • Lalani M, Kaur H, Mohammed N, Mailk N, van Wyk A, et al. 2015. Substandard antimalarials available in Afghanistan: a case for assessing the quality of drugs in resource poor settings. The American journal of tropical medicine and hygiene, 92(6 Suppl), pp.51-58.

    View at Publisher | View at Google Scholar
  • Shahzad S, Shah A, Sirajuddin M, Adhikari B, Ahmad K, et al. 2014. Synthesis, spectroscopic characterization, pH dependent redox mechanism and DNA binding behavior of chlorohydroxyaniline derivatives. RSC Advances, 4(43), pp.22299-22307.

    View at Publisher | View at Google Scholar
  • Hamilton WL, Doyle C, Halliwell-Ewen M and Lambert G, 2016. Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies. Health Policy and Planning, p.czw062.

    View at Publisher | View at Google Scholar
  • Habyalimana V, Mbinze JK, Tshilombo NK, Dispas A, Loconon AY, et al. 2015. Analytical tools and strategic approach to detect poor quality medicines, identify unknown components, and timely alerts for appropriate measures: case study of antimalarial medicines. American Journal of Analytical Chemistry, 6(13), p.977.

    View at Publisher | View at Google Scholar
  • Chaccour C, Kaur H and Del Pozo JL, 2015. Falsified antimalarials: a minireview. Expert review of anti-infective therapy, 13(4), pp.505-509.

    View at Publisher | View at Google Scholar
  • Geremedhin G, Bisrat D and Asres K, 2014. Isolation, Characterization and In Vivo Antimalarial Evaluation of Anthrones from the Leaf Latex of Aloe percrassa Todaro. Journal of Natural Remedies, 14(2), pp.119-125.

    View at Publisher | View at Google Scholar
  • Harris GA, 2011. Fundamentals of ambient metastable-induced chemical ionization mass spectrometry and atmospheric pressure ion mobility spectrometry (Doctoral dissertation, Georgia Institute of Technology).

    View at Publisher | View at Google Scholar
  • Suleman S, Verheust Y, Dumoulin A, Wynendaele E, D'Hondt M, et al. 2015. Gas chromatographic method for the determination of lumefantrine in antimalarial finished pharmaceutical products. journal of food and drug analysis, 23(3), pp.552-559.

    View at Publisher | View at Google Scholar
  • Khuluza F, Kigera S, Jähnke RW and Heide L, 2016. Use of thin-layer chromatography to detect counterfeit sulfadoxine/pyrimethamine tablets with the wrong active ingredient in Malawi. Malaria journal, 15(1), p.215.

    View at Publisher | View at Google Scholar
  • Hall Z, Allan EL, van Schalkwyk DA, van Wyk A and Kaur H, 2016. Degradation of artemisinin-based combination therapies under tropical conditions. The American journal of tropical medicine and hygiene, pp.15-0665.

    View at Publisher | View at Google Scholar
  • Grobusch MP and Schellenberg D, 2010. The rapidly changing world of malaria: where do we stand, and where do we go from here?. Therapy, 7(1), pp.1-2.

    View at Publisher | View at Google Scholar
  • Oral V and Andaç SÇ, 2015. A literature review of analytical methods used for identification and determination of counterfeit drugs. Journal of Faculty Pharmacy of Istanbul University, 45(2), pp.253-266.

    View at Publisher | View at Google Scholar
  • Visser BJ, 2017. Fats & Fakes.

    View at Publisher | View at Google Scholar
  • Visser BJ, Vries SG, Bache EB, Meerveld-Gerrits J, Kroon D, et al. 2016. The diagnostic accuracy of the hand-held Raman spectrometer for the identification of anti-malarial drugs. Malaria journal, 15(1), p.160.

    View at Publisher | View at Google Scholar
  • Rani S, Malik AK, Kaur R and Kaur R, 2016. A Review for the Analysis of Antidepressant, Antiepileptic and Quinolone Type Drugs in Pharmaceuticals and Environmental Samples. Critical Reviews in Analytical Chemistry, 46(5), pp.424-442.

    View at Publisher | View at Google Scholar
  • Alhassan AL, 2015. Method development for the simultaneous determination and quantification of artemether lumefantrine in anti malaria formulation using high performance liquid chromatography (Doctoral dissertation).

    View at Publisher | View at Google Scholar
  • Chikowe I, 2013. Post Marketing Surveillance Of Active Pharmaceutical Ingredients (Api) In Antimalarial Drugs Used In Malawi (Doctoral dissertation, University of Ghana).

    View at Publisher | View at Google Scholar
  • Bernier MC, Li F, Musselman B, Newton PN and Fernández FM, 2016. Fingerprinting of falsified artemisinin combination therapies via direct analysis in real time coupled to a compact single quadrupole mass spectrometer. Analytical Methods, 8(36), pp.6616-6624.

    View at Publisher | View at Google Scholar
  • Kaur H, Clarke S, Lalani M, Phanouvong S, Guérin P, et al. 2016. Fake anti-malarials: start with the facts. Malaria journal, 15(1), p.86.

    View at Publisher | View at Google Scholar
  • Sholy LB, 2015. Nature, extent, awareness, and attitudes towards counterfeit medicine in Lebanon (Doctoral dissertation, University of Brighton).

    View at Publisher | View at Google Scholar
  • Arlen PM, 2008. Novel approaches for the treatment of prostate cancer.

    View at Publisher | View at Google Scholar
  • Grobusch MP and Schellenberg D, 2010. The rapidly changing world of malaria: where do we stand, and where do we go from here?. Therapy, 7(1), pp.1-2.

    View at Publisher | View at Google Scholar
  • Smith RD, Chanda R and Tangcharoensathien V, 2009. Trade in health-related services. The Lancet, 373(9663), pp.593-601.

    View at Publisher | View at Google Scholar
  • Paller CJ, Carducci MA and Philips GK, 2012. Management of bone metastases in refractory prostate cancer–role of denosumab. Clin Interv Aging, 7, pp.363-372.

    View at Publisher | View at Google Scholar
  • Walsh PC, 2012. Re: Denosumab and Bone-Metastasis-Free Survival in Men With Castration-Resistant Prostate Cancer: Results of a Phase 3, Randomised, Placebo-Controlled Trial. The Journal of urology, 187(6), p.2098.

    View at Publisher | View at Google Scholar
  • Arlen PM, 2008. Novel approaches for the treatment of prostate cancer.

    View at Publisher | View at Google Scholar
  • Rusakov IG, Kosov AA And Mishugin SV, 2012. Place of drug therapy in the prevention and treatment of bone complications of prostate cancer. PHARMATEC, (18), pp. 24-28.

    View at Publisher | View at Google Scholar
  • Ahrén B, 2009. Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes. Nature reviews Drug discovery, 8(5), pp.369-385.

    View at Publisher | View at Google Scholar
  • Ahrén B, 2009. Clinical results of treating type 2 diabetic patients with sitagliptin, vildagliptin or saxagliptin–diabetes control and potential adverse events. Best Practice & Research Clinical Endocrinology & Metabolism, 23(4), pp.487-498.

    View at Publisher | View at Google Scholar
  • Ahrén B, 2008. Emerging dipeptidyl peptidase-4 inhibitors for the treatment of diabetes. Expert opinion on emerging drugs, 13(4), pp.593-607.

    View at Publisher | View at Google Scholar
  • Ahrén B, Foley JE and Bosi E, 2011. Clinical evidence and mechanistic basis for vildagliptin's action when added to metformin. Diabetes, Obesity and Metabolism, 13(3), pp.193-203.

    View at Publisher | View at Google Scholar
  • Lotfy M, Singh J, Kalász H, Tekes K and Adeghate E, 2011. Medicinal chemistry and applications of incretins and DPP-4 inhibitors in the treatment of type 2 diabetes mellitus. The open medicinal chemistry journal, 5(1).

    View at Publisher | View at Google Scholar
  • Park HJ, Lee OS and Imsongsil, 2012. Evaluation of drug use of sitagliptin and vildagliptin among dipeptidyl peptidase 4 inhibitors in Korean type 2 diabetic patients. Journal of Pharmacology, 56, pp.136-143.

    View at Publisher | View at Google Scholar
  • Moscatiello S, Montesi L, Forlani G and Marchesini G, 2011. Il monitoraggio AIFA dei nuovi farmaci per il trattamento del diabete. G It Diabetol Metab, 31, pp.76-81.

    View at Publisher | View at Google Scholar
Recommended Conferences

International Conference on Clinical Trials and Case Reports

Toronto, Canada

4th International Conference on Toxicology and Clinical Toxicology

Dubai, United Arab Emirates
izmir bayan escort escort izmir bursa escort antalya escort kızlar izmir escort porno porno indir porno izle escort bartın escort burdur escort eskişehir havalandırma sistemleri porno izmir escort bursa escort porno izle indir izmir escort bayan